Replies to post #55381 on Ariad Pharmaceuticals Inc fka ARIA

[trading_cyclist]

Agreed. What I thought was interesting was that even IF there is a financing problem, the outcome would likely still be positive for many investors that got in post crash...BO at multiples of current pps. Hence the siliness of the sideways, Bk, doom and gloom scenarios. ..and that conclusion extrapolated from the discourse of a doom and gloomer.

[Awlau]

There is no more royalty payments from bellicum. That is also a lot of "what ifs" there concerning partnerships of pona indications. While I'm not as negative as some posters here, this is one post that I disagree with vehemently. If funding is our least worry then what would you consider to be ariads biggest concern moving forward? Imo, we go no where without a longer runway as all those pona indications, and 113, are unreliable revenue streams without more money in the bank to fund development. As I stated before, I don't see this company going to BK, but I also don't think a BO is the worst possible outcome for Ariad investors. A BO not only gives a return to some peoples investment that may be deep underwater, it also gives ariad science the money it needs to reach its potential.